| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1041003520 |
| P356 | DOI | 10.1038/SJ.ONC.1201448 |
| P698 | PubMed publication ID | 9400999 |
| P2093 | author name string | Shridhar V | |
| Smith DI | |||
| Miller OJ | |||
| Petros J | |||
| Kalemkerian GP | |||
| Sun QC | |||
| P433 | issue | 22 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | heterozygosity | Q124059385 |
| P304 | page(s) | 2727-2733 | |
| P577 | publication date | 1997-11-01 | |
| P1433 | published in | Oncogene | Q1568657 |
| P1476 | title | Loss of heterozygosity on the long arm of human chromosome 7 in sporadic renal cell carcinomas | |
| P478 | volume | 15 |
| Q42796318 | 7q31-32 allelic loss is a frequent finding in splenic marginal zone lymphoma |
| Q35791457 | Absence of caveolin-1 sensitizes mouse skin to carcinogen-induced epidermal hyperplasia and tumor formation |
| Q34134938 | Allelic loss and reduced expression of the ING3, a candidate tumor suppressor gene at 7q31, in human head and neck cancers |
| Q47978602 | Analysis of the CAVEOLIN-1 gene at human chromosome 7q31.1 in primary tumours and tumour-derived cell lines |
| Q34104057 | Anti-tumor activity of fenretinide complexed with human serum albumin in lung cancer xenograft mouse model |
| Q34515728 | Are common fragile sites merely structural domains or highly organized "functional" units susceptible to oncogenic stress? |
| Q35070726 | Caveolin-1 deficiency (-/-) conveys premalignant alterations in mammary epithelia, with abnormal lumen formation, growth factor independence, and cell invasiveness |
| Q56101210 | Caveolin-1 expression in human breast lobular cancer progression |
| Q28363368 | Caveolin-1 is down-regulated in human ovarian carcinoma and acts as a candidate tumor suppressor gene |
| Q35789293 | Caveolin-1 mutations (P132L and null) and the pathogenesis of breast cancer: caveolin-1 (P132L) behaves in a dominant-negative manner and caveolin-1 (-/-) null mice show mammary epithelial cell hyperplasia |
| Q33244639 | Caveolin-1 mutations in human breast cancer: functional association with estrogen receptor alpha-positive status |
| Q43678714 | Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities |
| Q36671655 | Caveolin-1 overexpression predicts poor disease-free survival of patients with clinically confined renal cell carcinoma |
| Q28566101 | Caveolin-1 sensitizes rat pituitary adenoma GH3 cells to bromocriptine induced apoptosis |
| Q47852031 | Chromosomal localization, genomic organization, and developmental expression of the murine caveolin gene family (Cav-1, -2, and -3). Cav-1 and Cav-2 genes map to a known tumor suppressor locus (6-A2/7q31). |
| Q33220432 | Clonal divergence and genetic heterogeneity in clear cell renal cell carcinomas with sarcomatoid transformation |
| Q34557827 | Common fragile site tumor suppressor genes and corresponding mouse models of cancer |
| Q35575173 | Construction of a high-resolution physical map of the approximate 1-Mb region of human chromosome 7q31.1-q31.2 harboring a putative tumor suppressor gene |
| Q33733232 | DNA copy number losses in human neoplasms |
| Q40887234 | Definitive functional evidence for a tumor suppressor gene on human chromosome 7q31.1 neighboring the Fra7G site |
| Q28359685 | Down-regulation of caveolin-1, a candidate tumor suppressor gene, in sarcomas |
| Q28287729 | Genes encoding human caveolin-1 and -2 are co-localized to the D7S522 locus (7q31.1), a known fragile site (FRA7G) that is frequently deleted in human cancers |
| Q28304574 | Identification of ATF-3, caveolin-1, DLC-1, and NM23-H2 as putative antitumorigenic, progesterone-regulated genes for ovarian cancer cells by gene profiling |
| Q47152490 | Increased Incidence of Tumors With the IKBKAP Gene Mutation? A Case Report and Review of the Literature |
| Q24534385 | Knockout mice reveal a tumor suppressor function for Testin |
| Q78171358 | Localization of a novel tumor suppressor gene associated with human oral cancer on chromosome 4q25 |
| Q34813351 | Loss of caveolin-1 gene expression accelerates the development of dysplastic mammary lesions in tumor-prone transgenic mice |
| Q40705179 | Loss of heterozygosity on chromosome 7q in in vitro-immortalized human oral keratinocyte cell lines |
| Q28209312 | Mutational and functional analyses reveal that ST7 is a highly conserved tumor-suppressor gene on human chromosome 7q31 |
| Q37340493 | Mutations in the ST7/RAY1/HELG locus rarely occur in primary colorectal, gastric, and hepatocellular carcinomas |
| Q39658876 | RNA interference-directed caveolin-1 knockdown sensitizes SN12CPM6 cells to doxorubicin-induced apoptosis and reduces lung metastasis |
| Q36559674 | Regulation of Cripto-1 signaling and biological activity by caveolin-1 in mammary epithelial cells |
| Q28504937 | ST7-mediated suppression of tumorigenicity of prostate cancer cells is characterized by remodeling of the extracellular matrix |
| Q56602281 | Sequence and detailed organization of the human caveolin-1 and -2 genes located near the D7S522 locus (7q31.1) |
| Q28142435 | Sequence and detailed organization of the human caveolin-1 and -2 genes located near the D7S522 locus (7q31.1). Methylation of a CpG island in the 5' promoter region of the caveolin-1 gene in human breast cancer cell lines |
| Q37564565 | TES inhibits colorectal cancer progression through activation of p38. |
| Q33890028 | Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade |
| Q57788515 | The Role of Testin in Human Cancers |
| Q24291361 | The TES gene at 7q31.1 is methylated in tumours and encodes a novel growth-suppressing LIM domain protein |
Search more.